Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
312,433,269
-
Share change
-
+25,043,282
-
Total reported value
-
$11,849,433,951
-
Put/Call ratio
-
57%
-
Price per share
-
$37.89
-
Number of holders
-
809
-
Value change
-
+$918,476,440
-
Number of buys
-
329
-
Number of sells
-
459
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2020
As of 31 Mar 2020,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
809 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
312,433,269 shares.
The largest 10 holders included
Dodge & Cox, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, ROYAL BANK OF CANADA, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, Capital International Investors, Boston Partners, STATE STREET CORP, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This page lists
809
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.